|
1
|
Acloque H, Thiery JP and Nieto MA: The
physiology and pathology of the EMT. Meeting on the
epithelial-mesenchymal transition. EMBO Rep. 9:322–326. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luke C, Tracey E, Stapleton A and Roder D:
Exploring contrary trends in bladder cancer incidence, mortality
and survival: Implications for research and cancer control. Intern
Med J. 40:357–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Rhijn BW, Burger M, Lotan Y, Solsona
E, Stief CG, Sylvester RJ, Witjes JA and Zlotta AR: Recurrence and
progression of disease in non-muscle-invasive bladder cancer: From
epidemiology to treatment strategy. Eur Urol. 56:430–442. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan YG, Eu E, Kam Lau On W and Huang HH:
Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival
outcomes and advanced tumor staging in patients undergoing radical
cystectomy for bladder cancer. Asian J Urol. 4:239–246. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Urquidi V, Netherton M, Gomes-Giacoia E,
Serie DJ, Eckel-Passow J, Rosser CJ and Goodison S: A microRNA
biomarker panel for the non-invasive detection of bladder cancer.
Oncotarget. 7:86290–86299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Falzone L, Candido S, Salemi R, Basile MS,
Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M and
Libra M: Computational identification of microRNAs associated to
both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer. Oncotarget. 7:72758–72766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amir S and Mabjeesh NJ: microRNA
expression profiles as decision-making biomarkers in the management
of bladder cancer. Histol Histopathol. 32:107–119. 2017.PubMed/NCBI
|
|
9
|
Shin SS, Park SS, Hwang B, Moon B, Kim WT,
Kim WJ and Moon SK: MicroRNA-892b influences proliferation,
migration and invasion of bladder cancer cells by mediating the
p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways. Oncol
Rep. 36:2313–2320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang D, Qiu C, Zhang H, Wang J, Cui Q and
Yin Y: Human microRNA oncogenes and tumor suppressors show
significantly different biological patterns: From functions to
targets. PLoS One. 5:52010.
|
|
12
|
Tang J, Ahmad A and Sarkar FH: The role of
microRNAs in breast cancer migration, invasion and metastasis. Int
J Mol Sci. 13:13414–13437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Zhang J, Wang H, Zhao J, Xu C, Du
Y, Luo X, Zheng F, Liu R, Zhang H, et al: miRNA-135a promotes
breast cancer cell migration and invasion by targeting
HOXA10. BMC Cancer. 12:1112012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ochoa AE, Choi W, Su X, Siefker-Radtke A,
Czerniak B, Dinney C and McConkey DJ: Specific micro-RNA expression
patterns distinguish the basal and luminal subtypes of
muscle-invasive bladder cancer. Oncotarget. 7:80164–80174. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burmistrova OA, Goltsov AY, Abramova LI,
Kaleda VG, Orlova VA and Rogaev EI: MicroRNA in schizophrenia:
Genetic and expression analysis of miR-130b (22q11). Biochemistry.
72:578–582. 2007.PubMed/NCBI
|
|
16
|
Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM,
Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a
4-microRNA signature for clear cell renal cell carcinoma metastasis
and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang RM, Xu JF, Fang F, Yang H and Yang
LY: MicroRNA-130b promotes proliferation and EMT-induced metastasis
via PTEN/p-AKT/HIF-1α signaling. Tumour Biol. 37:10609–10619. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yip L, Kelly L, Shuai Y, Armstrong MJ,
Nikiforov YE, Carty SE and Nikiforova MN: MicroRNA signature
distinguishes the degree of aggressiveness of papillary thyroid
carcinoma. Ann Surg Oncol. 18:2035–2041. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong P, Karaayvaz M, Jia N, Kaneuchi M,
Hamada J, Watari H, Sudo S, Ju J and Sakuragi N: Mutant p53
gain-of-function induces epithelial-mesenchymal transition through
modulation of the miR-130b-ZEB1 axis. Oncogene. 32:3286–3295. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Q, Zhao X, Zhang H, Yuan H, Zhu M,
Sun Q, Lai X, Wang Y, Huang J, Yan J, et al: MiR-130b suppresses
prostate cancer metastasis through down-regulation of MMP2. Mol
Carcinog. 54:1292–1300. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gabriel BM, Hamilton DL, Tremblay AM and
Wackerhage H: The Hippo signal transduction network for exercise
physiologists. J Appl Physiol 1985. 120:1105–1117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiao S, Wang H, Shi Z, Dong A, Zhang W,
Song X, He F, Wang Y, Zhang Z, Wang W, et al: A peptide mimicking
VGLL4 function acts as a YAP antagonist therapy against gastric
cancer. Cancer Cell. 25:166–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mann KM, Ward JM, Yew CC, Kovochich A,
Dawson DW, Black MA, Brett BT, Sheetz TE and Dupuy AJ: Australian
Pancreatic Cancer Genome Initiative, Chang DK, Biankin AV, Waddell
N, Kassahn KS, Grimmond SM, Rust AG, Adams DJ, Jenkins NA and
Copeland NG: Sleeping Beauty mutagenesis reveals cooperating
mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad
Sci USA. 109:5934–5941. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang W, Gao Y, Li P, Shi Z, Guo T, Li F,
Han X, Feng Y, Zheng C, Wang Z, et al: VGLL4 functions as a new
tumor suppressor in lung cancer by negatively regulating the
YAP-TEAD transcriptional complex. Cell Res. 24:331–343. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang W, Yao F and He J, Lv B, Fang W, Zhu
W, He G, Chen J and He J: Downregulation of VGLL4 in the
progression of esophageal squamous cell carcinoma. Tumour Biol.
36:1289–1297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Wang Z, Zhang W, Qian K, Liao G, Xu
W and Zhang S: VGLL4 inhibits EMT in part through suppressing
Wnt/β-catenin signaling pathway in gastric cancer. Med Oncol.
32:832015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li N, Yu N, Wang J, Xi H, Lu W, Xu H, Deng
M, Zheng G and Liu H: miR-222/VGLL4/YAP-TEAD1 regulatory loop
promotes proliferation and invasion of gastric cancer cells. Am J
Cancer Res. 5:1158–1168. 2015.PubMed/NCBI
|
|
29
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bibi F, Naseer MI, Alvi SA, Yasir M,
Jiman-Fatani AA, Sawan A, Abuzenadah AM, Al-Qahtani MH and Azhar
EI: microRNA analysis of gastric cancer patients from Saudi Arabian
population. BMC Genomics. 17 Suppl 9:S7512016. View Article : Google Scholar
|
|
31
|
Li M, Li J, Ding X, He M and Cheng SY:
microRNA and cancer. AAPS J. 12:309–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng Y, Zhang X and Li P, Yang C, Tang J,
Deng X, Yang X, Tao J, Lu Q and Li P: MiR-200c promotes bladder
cancer cell migration and invasion by directly targeting RECK. Onco
Targets Ther. 9:5091–5099. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang B, Zhai W, Hu G, Huang C, Xie T,
Zhang J and Xu Y: MicroRNA-206 acts as a tumor suppressor in
bladder cancer via targeting YRDC. Am J Transl Res. 8:4705–4715.
2016.PubMed/NCBI
|
|
34
|
Pospisilova S, Pazourkova E, Horinek A,
Brisuda A, Svobodova I, Soukup V, Hrbacek J, Capoun O, Hanus T,
Mares J, et al: MicroRNAs in urine supernatant as potential
non-invasive markers for bladder cancer detection. Neoplasma.
63:799–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koontz LM, Liu-Chittenden Y, Yin F, Zheng
Y, Yu J, Huang B, Chen Q, Wu S and Pan D: The Hippo effector Yorkie
controls normal tissue growth by antagonizing scalloped-mediated
default repression. Dev Cell. 25:388–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dong L, Lin F, Wu W, Huang W and Cai Z:
Transcriptional cofactor Mask2 is required for YAP-induced cell
growth and migration in bladder cancer cell. J Cancer. 7:2132–2138.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ciamporcero E, Daga M, Pizzimenti S,
Roetto A, Dianzani C, Compagnone A, Palmieri A, Ullio C, Cangemi L,
Pili R, et al: Crosstalk between Nrf2 and YAP contributes to
maintaining the antioxidant potential and chemoresistance in
bladder cancer. Free Radic Biol Med. 115:447–457. 2018. View Article : Google Scholar : PubMed/NCBI
|
